
Parts of the globe are still ravished by diseases that are unheard of in industrialized societies, but there’s no money or motivation to make treatment available.

Parts of the globe are still ravished by diseases that are unheard of in industrialized societies, but there’s no money or motivation to make treatment available.

Drug giant GlaxoSmithKline will pay an estimated 3 Billion dollars in fines after pleading guilty to flooding the market with products that were dangerous and sometimes deadly to consumers.

October 1, 2011, came and went without any debate and almost no discussion regarding a missed deadline of a low profile but consumer friendly provision in the Affordable Heath Care Act (AHCA)—a provision requiring full disclosure by drug and medical device companies of all gifts, money, speaking fees or any other type of payment to a doctor or his staff by the companies.